PHIM Responsive Header

Tag: WHO

  • Mpox Situation in Malawi.

    Mpox Situation in Malawi.

    Mpox Situation in Malawi – Comprehensive Analysis
    Mpox Issue 73 | Current Status

    Epidemiological
    Intelligence

    Surveillance Update: 20th January, 2026

    PUBLISHED BY

    Moses Nyambalo Phiri

    Executive Case Briefing

    On 18th January 2026, the Public Health Institute of Malawi confirmed a new case in Salima District involving an 18-year-old female. This diagnostic confirmation, occurring 12 days after the initial hospital presentation, underscores the vital importance of molecular validation in managing the current outbreak, which has now accumulated 148 confirmed cases.

    148

    National Total

    01

    New Salima Case

    Clinical presentation of suspected Mpox lesions
    Primary Symptom: Characteristic Cutaneous Lesions

    Fig A: Typical clinical presentation observed in recent Central Region cases.

    Operational Response & Data Insights

    District Sentinel Analysis

    The notification from Salima District hospital on January 6th, followed by PCR confirmation on the 18th, highlights a critical window for containment. The Salima District Rapid Response Team (DRRT) has prioritized contact tracing around this 18-year-old female, who represents a significant demographic shift as younger populations increasingly become points of entry for the virus in rural settings.

    Operationally, the focus is now on “Ring Surveillance.” By mapping the patient’s interactions within the 21-day incubation period, the DRRT is effectively creating a safety perimeter. This prevents the transition from a sporadic case to a localized cluster, which is essential given Salima’s role as a transit and tourism hub that could easily facilitate cross-district transmission.

    One Health Surveillance Matrix

    The activation of the Incident Management System (IMS) signifies a transition to high-alert status. This multisectoral One Health approach is critical because it integrates human clinical data with animal health monitoring. Understanding the zoonotic potential of Mpox in Malawi is key to identifying the environmental reservoirs that might be driving these persistent “sporadic” infections across different districts.

    Furthermore, the IMS structure allows for real-time resource reallocation. As shown in the surveillance matrix, deployment of functional Rapid Response Teams (RRTs) is not static; it follows the trajectory of new confirmations. The training of National Emergency Medical Teams ensures that the surge capacity is prepared for any sudden spikes in severity or volume that may arise as the virus moves through the lake-shore communities.

    Diagnostic Efficiency Trends

    Diagnostic integrity is the cornerstone of the Malawi Mpox response. The PCR-based testing of lesion swabs provides the definitive evidence needed to trigger public health interventions. While the turnaround time for the Salima case reflects the logistical challenges of sample transport from district to central labs, the successful confirmation demonstrates a robust end-to-end diagnostic pipeline that can handle highly infectious specimens.

    Looking forward, the focus is on reducing the “symptom-to-confirmation” latency. By empowering district-level human and animal health workers through advanced training, PHIM aims to improve early suspicion and immediate sample collection. This diagnostic intelligence ensures that clinical management, including isolation and symptomatic treatment, begins at the earliest possible stage, significantly improving patient outcomes and reducing secondary attack rates.

    Specialized Mpox Isolation Units

    Containment Strategy: Infrastructure & Resilience

    The strategic deployment of dedicated Mpox Isolation Units is a vital component of Malawi’s health system resilience. By physically separating Mpox management from general medical wards, PHIM effectively mitigates the risk of nosocomial transmission. These units are not merely physical structures; they represent a specialized clinical ecosystem equipped with advanced waste management protocols and high-frequency disinfection cycles, ensuring that healthcare workers remain protected while delivering intensive supportive care.

    Beyond the immediate benefit of containment, these facilities foster clinical excellence through specialization. Staff assigned to these units are trained in specific lesion care, pain management, and the identification of secondary bacterial infections. This concentrated expertise is particularly crucial for younger patients, such as the 18-year-old from Salima, ensuring they receive evidence-based care in a dignifying and safe environment that prioritizes both physical recovery and community protection.

    Macro-Level Data Analysis

    1. Cumulative Geographic Burden (n=148)

    The distribution of 148 laboratory-confirmed cases reveals a persistent, low-intensity spread that spans across multiple regions. While large urban centers initially dominated the statistics, the recent case in Salima demonstrates that the virus is successfully exploiting mobility corridors. This geographic burden analysis suggests that surveillance cannot be localized; rather, a nationwide “blanket” surveillance approach is necessary to capture infections in districts that may not have high healthcare-seeking behavior but are nonetheless at risk.

    Strategically, this data indicates that the 148 cases represent only the “tip of the iceberg.” For every confirmed case, there is a statistical likelihood of sub-clinical or asymptomatic cases within the community. Public health efforts are therefore prioritizing districts with high population density and frequent transit, using this geographic data to allocate diagnostic kits and protective equipment where they are most likely to encounter the next “sentinel” case.

    2. National Epicurve & Temporal Dynamics

    The national epicurve illustrates the temporal progression of the outbreak since April 2025. Unlike explosive outbreaks, Mpox in Malawi exhibits a “smoldering” pattern, with sporadic cases occurring regularly over several months. The confirmation of Case 148 in late January 2026 confirms that the transmission cycle has not been broken. This trend analysis is vital for predicting seasonal peaks and ensuring that the healthcare system is prepared for sustained engagement rather than a short-term emergency response.

    Mathematically, the presence of the Salima case on the tail end of this curve suggests that the virus remains endemic in certain reservoirs. The epicurve analysis informs our Risk Communication and Community Engagement (RCCE) strategies—shifting from high-volume general awareness to targeted, behavior-change messaging in districts showing new activity. Constant vigilance is required to ensure that this smoldering trend does not ignite into a large-scale resurgence as environmental and social conditions fluctuate.

    Preventative Clinical Directives

    Public Safety Protocols

    • Zero Contact: Avoid all skin-to-skin contact with individuals presenting unexplained rashes or blisters.
    • Sanitization: Mandatory hand hygiene with soap and water or alcohol-based sanitizers in all public transit hubs.
    • Immediate Reporting: Any individual with fever and rash must report to the nearest health facility within 24 hours.

    Surveillance Mandate

    Following the Salima case, PHIM has mandated enhanced surveillance for all district hospitals. Health workers are directed to treat all “Fever + Rash” presentations as suspected Mpox until PCR results prove otherwise. This high-index of suspicion is our primary defense against widespread community transmission.

  • PHIM and Partners Strengthens National Public Health Emergency Response Capacity Through PHEOC Training.

    PHIM and Partners Strengthens National Public Health Emergency Response Capacity Through PHEOC Training.

    NPHEOC TRAINING 2025.

    Sunbird Capital, Lilongwe, Malawi – March 18th, 2025.
    by
    Moses Nyambalo Phiri in collaboration with Ella Chamanga, Francis Chimphanje and Settie Kanyanda.

    The Public Health Institute of Malawi (PHIM) with funding from the World Bank is currently conducting a critical Public Health Emergency Operation Centre (PHEOC) training for national-level staff and subject matter experts. Technical support has been provided by WHO, and the US-CDC Malawi Country Office. The PHEOC serves as the central hub for cordinating preparedness, prevention, detection, response, and mitigation efforts for public health emergencies at all levels. This intensive training program, held from March 18th to 24th, 2025, aims to significantly enhance Malawi’s preparedness and response capabilities to public health emergencies.

    The training was officially opened by Mr. Jospeh Bitilinyu Bango, Deputy Director for PHIM responsible for the National Public Health Laboratory (NPHL) on behalf of Dr. Mathew Kagoli, the Director. In his speech, he emphasized the crucial role this training exercise will render. He said “The knowledge and skills acquired during this training will be instrumental in equipping our district-level teams (DPHEOCs) in the coming weeks,” by highlighting the cascade effect of this national-level effort.

    This PHEOC training builds upon the foundation laid by the inaugural session held about two years ago by WHO and Africa CDC experts. The on coming follow up District PHEOC (DPHEOC) trainings shall ensure a comprehensive and robust emergency response network across the country.

    Recognizing the pivotal role of a well-coordinated multi-agency approach in mitigating public health threats, PHIM has organized this training to equip officers from the National PHEOC – including the ICT, Surveillance, EPR, Crossreference, IHR, and the Public Health Research Division and National Public Health Labolatory officers.

    Dr. Chitsa Banda, PHIM and Dr. Chapotera, WHO giving a lecture to trainees.

    In attendance also are experts from various response stakeholders including Central Veterinary Lab, Ministry of Water and Sanitation, Case Management, Operations Supplies and Logistics, Public Health Division, DODMA, EPI, Health Promotions Division, and the International partners WHO, and the US-CDC Malawi Country Office.

    Session in Progress ~ Group Discussions.

    This training has enhanced understanding of the operational procedures within the National PHEOC, strengthening inter-agency coordination during emergency responses and it has improved the application of expert knowledge across key response pillars.
  • Ebola Situation in Malawi

    Ebola Situation in Malawi

    PHIM Operational Briefing: The Smoldering Frontier
    EBOLA SITUATION IN MALAWI

    PHIMs Preparedness
    Partners Converge

    As intense outbreaks affect transport routes to our north, Malawi maintains a silent but critical window for prevention. Stopping local spread is our most effective strategy.

    Briefing Contributors

    Contributor Annie Kaliati
    Lead Contributor Mtisunge Yelewa
    Contributor Shaibu Safaile
    Briefing Released: June 2026

    Malawi Cases

    0

    Under Active Vigilance

    DRC & Uganda Cases

    1,200+

    Rapid Corridor Growth

    Regional Deaths

    264+

    Zaire Ebolavirus Severity

    Surveillance Level

    Level 3

    Pre-Resurgence Tier

    Briefing Context

    Diseases do not spread at random. They travel along busy roads, lakeshore routes, and trade pathways. While nearby countries like the Democratic Republic of the Congo (DRC) and Uganda are facing serious outbreaks of Ebola, Malawi currently has zero active cases.

    However, we cannot be relaxed. This quiet period is our only window of opportunity. We must prepare our communities, watch our borders, and stop transmission pathways before the virus can establish itself in our towns.

    THE NO-VACCINE REALITY

    Global vaccine supplies are very low. High-burden areas are receiving them first. Malawi will not get vaccines for general use anytime soon. Therefore, we must focus entirely on basic protective actions: hygiene, quick detection, and keeping sick people away from others.

    To keep our communities safe, we must find contacts immediately whenever a case is suspected. This is called Ring Surveillance. It helps us monitor anyone who has been close to an infected person within a strict 21-day window.

    Additionally, isolation must happen locally. Moving sick patients over long distances to central hospitals is dangerous. It risks spreading the virus along the way and puts unnecessary pressure on main healthcare facilities.

    THE DIAGNOSTIC LAG

    Testing currently takes too long. On average, it takes 12 days to send a sample from a local clinic and get a confirmation back. During this delay, sick individuals often return home, exposing others. We must decentralize sample collection to stop silent transmission.

    A clear leadership structure is essential during an epidemic response. When local containment efforts fail, it is usually because of confusion about who is in charge.

    To address this, the Incident Management System is coordinating animal health, laboratory, and clinical teams under a single, unified framework. We are giving local District Health Officers immediate power to act without waiting for permission from the capital.

    THE ACCOUNTABILITY GAP

    Central plans from Lilongwe will not work if local health offices do not have fuel, diagnostic tools, and personal protective equipment (PPE). We must connect national resources directly to local needs to ensure our frontline workers can do their jobs.

    We must use this quiet period to prepare. The threat along our borders is highly active, and imported cases are likely. Our success will be judged by how quickly our teams contain new arrivals and break the chain of transmission.

    “This is a harder test, it is also the right one.”

    By planning for a scenario with zero vaccines, shrinking diagnostic delays, and empowering our local districts, Malawi can build a strong and resilient defense against outbreaks.

    Immediate Public Reporting Hotline

    Reporting Suspected Symptoms

    Immediate isolation and reporting within 24 hours of fever and unexplained rash is legally mandated for all border corridors.

    Toll-Free Helpline 929 Public Health Emergency Center